全文获取类型
收费全文 | 1467409篇 |
免费 | 99446篇 |
国内免费 | 3208篇 |
专业分类
耳鼻咽喉 | 22029篇 |
儿科学 | 45011篇 |
妇产科学 | 41791篇 |
基础医学 | 205550篇 |
口腔科学 | 43744篇 |
临床医学 | 122626篇 |
内科学 | 285874篇 |
皮肤病学 | 34010篇 |
神经病学 | 118672篇 |
特种医学 | 60478篇 |
外国民族医学 | 455篇 |
外科学 | 229518篇 |
综合类 | 31982篇 |
现状与发展 | 6篇 |
一般理论 | 470篇 |
预防医学 | 98482篇 |
眼科学 | 35287篇 |
药学 | 109154篇 |
4篇 | |
中国医学 | 3292篇 |
肿瘤学 | 81628篇 |
出版年
2018年 | 14264篇 |
2017年 | 11617篇 |
2016年 | 13392篇 |
2015年 | 15023篇 |
2014年 | 20023篇 |
2013年 | 29971篇 |
2012年 | 40261篇 |
2011年 | 41666篇 |
2010年 | 24679篇 |
2009年 | 23401篇 |
2008年 | 40207篇 |
2007年 | 43931篇 |
2006年 | 44434篇 |
2005年 | 43494篇 |
2004年 | 42132篇 |
2003年 | 41056篇 |
2002年 | 40414篇 |
2001年 | 67661篇 |
2000年 | 69228篇 |
1999年 | 58850篇 |
1998年 | 15827篇 |
1997年 | 14366篇 |
1996年 | 13657篇 |
1995年 | 12796篇 |
1994年 | 12000篇 |
1992年 | 44218篇 |
1991年 | 42614篇 |
1990年 | 41894篇 |
1989年 | 40761篇 |
1988年 | 38033篇 |
1987年 | 37489篇 |
1986年 | 35843篇 |
1985年 | 34006篇 |
1984年 | 25555篇 |
1983年 | 21628篇 |
1982年 | 13090篇 |
1981年 | 11961篇 |
1979年 | 24708篇 |
1978年 | 17649篇 |
1977年 | 15311篇 |
1976年 | 13824篇 |
1975年 | 15841篇 |
1974年 | 18712篇 |
1973年 | 18135篇 |
1972年 | 17427篇 |
1971年 | 16301篇 |
1970年 | 15460篇 |
1969年 | 14831篇 |
1968年 | 13956篇 |
1967年 | 12453篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
M Wildgruber W Weiss H Berger O Wolf H-H Eckstein P Heider 《European journal of vascular and endovascular surgery》2007,34(1):35-43
OBJECTIVES: To assess prospectively the early time course of Transforming Growth Factor beta-1 (TGFbeta-1), basic Fibroblast Growth Factor (bFGF) and Tumor Necrosis Factor alpha (TNFalpha) as possible contributors to restenosis development after angioplasty. DESIGN: Prospective Study. METHODS: The levels of the soluble forms of these factors in the early response to Percutaneous Transluminal Angioplasty (PTA) in the arteries of the lower limb were prospectively assessed. 32 patients with peripheral arterial occlusive disease (PAOD), presenting with intermittent claudication (Fontaine stage IIb) were scheduled for angioplasty treatment. Serum levels of TGFbeta-1, TNFalpha and bFGF were assessed before intervention, 15 and 60 minutes after, 24 hours after as well as 2 and 4 weeks after intervention. We compared the distribution patterns between patients treated with balloon angioplasty and patients who required secondary stent implantation. Endpoint was the development of restenosis within 6 months after interventional treatment, defined as a lumen diameter reduction of more than 50% by ultrasound measurement compared to the result after PTA. RESULTS: The patients who later developed restenosis had significantly higher levels of TGFbeta-1 at 15 minutes, 24 hours and 2 weeks after PTA (p<0.05). TNFalpha and bFGF were only detected in a few patients and no significant change of serum levels was observed. CONCLUSION: The results demonstrate a possible role of TGFbeta-1 in the formation of restenosis after PTA. 相似文献
993.
994.
H Steyaert M Juricic C Hendrice M A Lembo M Al Mohaidly J Guitard J S Valla 《Zeitschrift für Kinderchirurgie》2003,13(2):112-115
Choosing the best way to approach adrenal gland and retroperitoneal tumours is still difficult. We reviewed our first 10 cases operated on by retroperitoneoscopy and compared this approach with other possible ways described in the literature. There were 2 intraoperative complications: 1 opening of the diaphragm and 1 bleeding. Tumour resection was always complete. There was no conversion. There were no postoperative complications. The retroperitoneoscopic approach for adrenalectomy and retroperitoneal tumour resection is increasingly being used. In children, operation is quite fast, without much blood loss and with spectacular postoperative recovery results. Even for the right side we advocate this approach, due to the particular anatomy (small tumour size, less fat, thinner muscle layers) in this age group. Trained surgeons are, of course, mandatory. 相似文献
995.
996.
Steven D. Wexner MD FACS FRCS FRCS Lester Rosen MD Todd H. Baron MD FASGE 《Gastrointestinal endoscopy》2007,65(7):1104-1105
997.
The Department of Health has funded a national diabetes network to support clinical research. The network will facilitate recruitment into clinical trials and has been widely welcomed by clinicians. However, if the network is to reach its full potential, all those involved will need to advocate a change in attitude towards clinical trials and research, encouraging participation and contribution of data. Clinicians need to be willing to take a proactive view about research studies, and to encourage patients to adopt a positive and altruistic attitude towards trial participation. The future of trials and other important clinical research in the UK may depend on it. 相似文献
998.
M Oishi H Yokoyama N Abe K Iwasaki F Okuguchi K Kawai H Sugimoto H Takamura H Takeda K Doi K Hirao S Ikeda 《Diabetic medicine》2007,24(10):1149-1155
AIMS: To study the time and cost involved in the care of newly registered outpatients with Type 2 diabetes mellitus (DM), compared with patients with hypertension and/or hyperlipidaemia (HTL). METHODS: A total of 313 patients with DM and 58 patients with HTL without diabetes were registered on their first visits to 11 diabetes clinics across Japan. The time and cost involved in their care was recorded over the following 5 months. RESULTS: In the first 3 months, there was an extensive time commitment to both groups. The time spent by physicians was 1.5 times longer for DM than for HTL. The total care time spent by all the care providers for DM was twice that for HTL. The cost of DM care was twice that for HTL, with the cost of medicines excluded. However, half of the cost for DM was for laboratory tests. When these were excluded, and the remaining cost divided by the time spent, the amount for DM was half of that for HTL. Over the 5 months, mean glycated haemoglobin (HbA(1c)) in DM patients improved from 8.0% to 6.5%, and 72% of DM patients achieved the glycaemic target of HbA(1c) < or = 6.5%. CONCLUSIONS: DM care in a diabetes clinic requires a great deal more time and resources than HTL to achieve the best outcome. An educational system for self care, presently lacking in the primary care setting in Japan, would improve glycaemic control for DM patients in the community. 相似文献
999.
F Reichenberger R Voswinckel B Enke M Rutsch E El Fechtali T Schmehl H Olschewski R Schermuly N Weissmann H A Ghofrani F Grimminger E Mayer W Seeger 《The European respiratory journal》2007,30(5):922-927
For chronic thromboembolic pulmonary hypertension not amenable to pulmonary endarterectomy, effective medical therapy is desired. In an open-label uncontrolled clinical trial, 104 patients (mean +/- sem age 62 +/- 11 yrs) with inoperable chronic thromboembolic pulmonary hypertension were treated with 50 mg sildenafil t.i.d. At baseline, patients had severe pulmonary hypertension (pulmonary vascular resistance 863 +/- 38 dyn.s.cm(-5)) and a 6-min walking distance of 310 +/- 11 m. Eight patients were in World Health Organization functional class II, 76 in class III and 20 in class IV. After 3 months' treatment, there was significant haemodynamic improvement, with reduction of pulmonary vascular resistance to 759 +/- 62 dyn.s.cm(-5). The 6-min walking distance increased significantly to 361 +/- 15 m after 3 months' treatment, and to 366 +/- 18 m after 12 months' treatment. A subset of 67 patients received a single dose of 50 mg sildenafil during initial right heart catheterisation. The acute haemodynamic effect of this was not predictive of long-term outcome. In this large series of patients with inoperable chronic thromboembolic pulmonary hypertension, open-label treatment with sildenafil led to significant long-term functional improvement. The acute effect of sildenafil may not predict the long-term outcome of therapy. 相似文献
1000.